Signing of a new tuberculosis initiative between the World Health Organization and the International Pharmaceutical Federation
5 September 2011 | Hyderabad | In a landmark initiative aimed at curbing the current tuberculosis (TB) epidemic, the World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) today signed a Joint Statement on the role of pharmacists in tuberculosis care and control at the Federation's 71st International Congress in Hyderabad, India.
31 August 2011 | Geneva | WHO and the International Union Against TB and Lung Disease (The Union) have developed a Collaborative Framework for Care and Control of Tuberculosis and Diabetes which presents recommendations based on evidence from three systematic reviews and a series of expert consultations.
It outlines essential steps for coordinated action in three areas: establishment of mechanisms for collaboration between national TB programmes and suitable counterparts responsible for care and control of diabetes; improved detection and management of TB in patients with diabetes; improved detection and management of diabetes in patients with TB.
29 August 2011 | Geneva | Evidence from operational research projects can help pave the way for ensuring many more people have access to vital TB health services. It can achieve this by shedding new light on how current TB polices and practices can be 'fine-tuned' and further improved. It can also give important insight on how best new tools for TB, currently in development, can be introduced in ways that deliver maximum benefits.
Priorities in operational research to improve tuberculosis care and control describes the current areas where gaps in knowledge are hindering the optimal implementation of TB control activities and how these obstacles can be removed.
10 August 2011 | Geneva |
WHO has issued a 2011 update of the Guidelines for programmatic management of drug-resistant tuberculosis.
The guidelines support the 2009 World Health Assembly resolution (WHA62.15) to provide technical assistance to countries to develop and implement frameworks for the improved care of patients with drug-resistant TB.
- Signing of a new tuberculosis initiative between the World Health Organization and the International Pharmaceutical Federation
- Taking action on the link between TB and diabetes - launch of new collaborative framework
- 'Priorities in operational research to improve tuberculosis care and control'
- Guidelines for programmatic management of drug-resistant tuberculosis
Tuberculosis (TB) is an airborne infectious disease that is preventable and curable. WHO is working to dramatically reduce the burden of TB, and halve TB deaths and prevalence by 2015, through its Stop TB Strategy and supporting the Global Plan to Stop TB.